Cybiont: Commercial Real Estate 3Q24 Update

Each quarter we consider trends in loan quality at publicly traded commercial banks. With all eyes on Commercial Real Estate (ComRe), we present the stock and flow of underperforming ComRe loans1 from over 700 commercial banks by asset class.

Levels and trends in underperforming loans continues to be most concerning at banks over $10 billion (120 companies in our universe) (See feature graph and Graph 1). Lower mid-curve rates during the third quarter appear to have slowed deterioration in the quarter for most banks with the exception of the median large bank where the Underperforming Loan Ratio continues the steady rise that started in 4Q22.

Chart 1

It’s likely, particularly within the sub-$10 billion cohorts, that the levels of underperforming assets are understated. Historically, smaller banks are slower to project loans that are likely to manifest debt service coverage ratios (DSCR) of less than 1 when these loans renew in a higher rate environment. Should mid-term rates tick up or remain higher for longer, the abating trends will likely reaccelerate as banks renew loans at higher rates.

Charts 1 through 3 show the stock and flow of underperforming ComRe loans by 3 asset size cohorts: Banks less than $1B in Assets (266 banks), Banks $1B to $10B in Assets (319 banks), and Banks over $10B in Assets (120 banks).

The charts are designed to visualize not only the central tenancies of levels and trends in underperforming ComRe loans but also the developing conditions in the extremities of the cohorts. For example, the upper dots show the conditions in the banks occupying the 80th worst percentile rank within each respective cohort.

Chart 2

Chart 3

  1. See Cybiont’s Granular View of Bank Credit Quality for definitions and methods. ↩︎

Author

  • 30-year career as a Bank & FinTech sector stakeholder with substantive roles as investor, policy maker, regulator, operator, analyst, strategist, and advisor.

    View all posts


Leave a Reply

About Us

We are your banking experts.

Private Equity: We are a trusted partner for family offices and other investors seeking to invest in U.S. banks in the private markets. We source investment opportunities and provide diligence services and ongoing monitoring of bank investments for family offices and other investors for whom we provide cost-effective confidence for their financial company investments.

Public Markets: We structure bank investment portfolios providing risk-tailored strategies by systematically integrating fundamental and technical analysis building alpha-generating long/short portfolios from the nearly 300 liquid publicly traded banking companies in the U.S. markets. If you want bank equity exposure with tailored risk parameter’s, we’re your source.

Cybiont is…

Our Investment Philosophy

Recieve Cybiont’s analysis in your email as it’s released:

Discover more from Cybiont Capital, LLC

Subscribe now to keep reading and get access to the full archive.

Continue reading

Discover more from Cybiont Capital, LLC

Subscribe now to keep reading and get access to the full archive.

Continue reading